Covered recipient · General Payments record
LAURA M DE ANDRADE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2023
$415.48
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $275.48 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $221.64 | 14 |
| Medtronic, Inc. | $25.42 | 1 |
| Currax Pharmaceuticals LLC | $14.82 | 1 |
| Cumberland Pharmaceuticals, Inc. | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, Inc. | $13.60 | 08/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052132007 | CMS |
| Currax Pharmaceuticals LLC | $14.82 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 986451799 | CMS |
| Medtronic, Inc. | $25.42 | 09/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026442381 | CMS |
| Novo Nordisk Inc | $8.22 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173481 | CMS |
| Novo Nordisk Inc | $6.36 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173433 | CMS |
| Novo Nordisk Inc | $6.76 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173445 | CMS |
| Novo Nordisk Inc | $2.82 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173409 | CMS |
| Novo Nordisk Inc | $3.56 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173421 | CMS |
| Novo Nordisk Inc | $7.35 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173457 | CMS |
| Novo Nordisk Inc | $2.19 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173382 | CMS |
| Novo Nordisk Inc | $8.43 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173495 | CMS |
| Novo Nordisk Inc | $1.16 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173371 | CMS |
| Novo Nordisk Inc | $18.31 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173507 | CMS |
| Novo Nordisk Inc | $124.99 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173531 | CMS |
| Novo Nordisk Inc | $7.61 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173469 | CMS |
| Novo Nordisk Inc | $2.41 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173397 | CMS |
| Novo Nordisk Inc | $21.47 | 11/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001173519 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.